YM-202074 sesquifumarate salt hydrate
SIGMA/Y1271 - ≥98% (HPLC)
Synonym: N-
CAS Number: 299900-84-8 (anhydrous)
Empirical Formula (Hill Notation): C22H30N4O2S · 1.5C4H4O4 · xH2O
Molecular Weight: 588.67 (anhydrous basis)
MDL Number: MFCD16879020
Linear Formula: C22H30N4O2S · 1.5C4H4O4 · xH2O
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white to off-white |
| form | powder |
| InChI | 1S/3C22H30N4O2S.2C4H4O4.H |
| InChI key | MCGFIZFYSARKON-RAMYONIISA |
| Quality Level | 100 ![]() |
| SMILES string | O.OC(=O)C=CC(O)=O.OC(=O |
| solubility | DMSO: >20 mg/mL |
| H2O: >5 mg/mL | |
| storage temp. | room temp |
| Biochem/physiol Actions: | YM-202074 is a potent and selective allosteric metabotropic glutamate receptor type 1 (mGluR1) antagonist. |
| Biochem/physiol Actions: | YM-202074 is a potent and selective allosteric metabotropic glutamate receptor type 1 (mGluR1) antagonist. It bound an allosteric site of rat mGluR1 with a Ki value of 4.8 nM. It also inhibited the mGluR1-mediated inositol phosphates production in rat cerebellar granule cells with an IC50 value of 8.6 nM, while showing selectivity over mGluR(2-7). |
| Packaging: | 5, 25 mg in glass bottle |
| Symbol | GHS06 |
| Signal word | Danger |
| Hazard statements | H301 - H319 |
| Precautionary statements | P301 + P310 + P330 - P305 + P351 + P338 |
| Hazard Codes | T |
| Risk Statements | 25-36 |
| Safety Statements | 26-45 |
| RIDADR | UN 2811 6.1 / PGIII |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | room temp |
| UNSPSC | 12352200 |


